help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Originally published online as doi:10.2353/ajpath.2008.080237 on September 11, 2008

Published online before print September 11, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
ajpath.2008.080237v1
173/4/1100    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Isenberg, J. S.
Right arrow Articles by Roberts, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Isenberg, J. S.
Right arrow Articles by Roberts, D. D.
(American Journal of Pathology. 2008;173:1100-1112.)
© 2008 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2008.080237

Thrombospondin-1 and CD47 Limit Cell and Tissue Survival of Radiation Injury

Jeff S. Isenberg*, Justin B. Maxhimer*, Fuminori Hyodo{dagger}, Michael L. Pendrak*, Lisa A. Ridnour{dagger}, William G. DeGraff{dagger}, Maria Tsokos*, David A. Wink{dagger} and David D. Roberts*

From the Laboratory of Pathology* and the Radiation Biology Branch,{dagger} Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Radiation, a primary mode of cancer therapy, acutely damages cellular macromolecules and DNA and elicits stress responses that lead to cell death. The known cytoprotective activity of nitric oxide (NO) is blocked by thrombospondin-1, a potent antagonist of NO/cGMP signaling in ischemic soft tissues, suggesting that thrombospondin-1 signaling via its receptor CD47 could correspondingly increase radiosensitivity. We show here that soft tissues in thrombospondin-1-null mice are remarkably resistant to radiation injury. Twelve hours after 25-Gy hindlimb irradiation, thrombospondin-1-null mice showed significantly less cell death in both muscle and bone marrow. Two months after irradiation, skin and muscle units in null mice showed minimal histological evidence of radiation injury and near full retention of mitochondrial function. Additionally, both tissue perfusion and acute vascular responses to NO were preserved in irradiated thrombospondin-1-null hindlimbs. The role of thrombospondin-1 in radiosensitization is specific because thrombospondin-2-null mice were not protected. However, mice lacking CD47 showed radioresistance similar to thrombospondin-1-null mice. Both thrombospondin-1- and CD47-dependent radiosensitization is cell autonomous because vascular cells isolated from the respective null mice showed dramatically increased survival and improved proliferative capacity after irradiation in vitro. Therefore, thrombospondin-1/CD47 antagonists may have selective radioprotective activity for normal tissues.




This article has been cited by other articles:


Home page
 Sci Transl MedHome page
J. B. Maxhimer, D. R. Soto-Pantoja, L. A. Ridnour, H. B. Shih, W. G. DeGraff, M. Tsokos, D. A. Wink, J. S. Isenberg, and D. D. Roberts
Radioprotection in Normal Tissue and Delayed Tumor Growth by Blockade of CD47 Signaling
Science Translational Medicine, October 21, 2009; 1(3): 3ra7 - 3ra7.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
O. Uluckan, S. N. Becker, H. Deng, W. Zou, J. L. Prior, D. Piwnica-Worms, W. A. Frazier, and K. N. Weilbaecher
CD47 Regulates Bone Mass and Tumor Metastasis to Bone
Cancer Res., April 1, 2009; 69(7): 3196 - 3204.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. S. Isenberg, D. S. Annis, M. L. Pendrak, M. Ptaszynska, W. A. Frazier, D. F. Mosher, and D. D. Roberts
Differential Interactions of Thrombospondin-1, -2, and -4 with CD47 and Effects on cGMP Signaling and Ischemic Injury Responses
J. Biol. Chem., January 9, 2009; 284(2): 1116 - 1125.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society for Investigative Pathology.